HADEAN VENTURES ANNOUNCES THE 1[ST] CLOSING OF EUR 90M FOR ITS SECOND FUND
Oslo, 27. September 2021.
· Hadean Capital II launched on the back of strong performance · Eur 90m raised for the first closing, exceeding total fund I size · Backed by leading Europe and US-based private and institutional investors
Hadean Ventures, a European life science fund manager, today announced the 1[st] closing of Hadean Capital II at EUR 90m, exceeding the total size of its inaugural fund, Hadean Capital I. The launch comes on the back of strong performance of Hadean Capital I, including the sale of Themis Bioscience GmbH to MSD/Merck.
Hadean Capital II will be